Lotfi Merabet, OD, PhD, MPH, discusses his role as co-chairman of a National Eye Institute initiative focused on advancing research in cerebral visual impairment (CVI). The initiative's key goals ...

Myopia is projected to affect half the global population by 2050, with myopic maculopathy leading to significant vision loss.

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

Jeff Todd, president and CEO of Prevent Blindness, and Donna Fishman, Director of the National Center for Children’s Vision and Eye Health at Prevent Blindness, join David Hutton of Ophthalmology ...

In a study, a team of UCLA investigators detail a deep-learning model pre-trained on 2D scans that accurately predicts ...

The award from the National Institutes of Health will enable a team of researchers to investigate Alzheimer and Parkinson ...

Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL) , TECNIS Odyssey, in the US.

Ciclosporin 0.1% eye drops solution will be marketed under the brand name Vevizye in the EU for the treatment of dry eye ...

CVD, an AI diagnostic solution that autonomously assesses future cardiovascular disease risk using a retina scan.

The donation will support the development of the Artificial Intelligence Innovation Center, a collaborative hub with a focus ...

Proviant Therapeutics announced the first patients have been enrolled in CLARITY, its phase 3 study ( NCT06431373) evaluating ...

Because the inner retinal function is thought to affect the emmetropization process, authors suggested that caffeine may be ...